Drugs / Autologous conditioned plasma (ACP)
last change Feb 2015 re-read 3 minutes ago

Autologous conditioned plasma (ACP)

Developed for
rotator cuff syndrome
Investigated by
Arthrex, Inc. · The University of Western Australia

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01414764 May 2011 → Jan 2015 rotator cuff syndrome The University of Western Australia Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous conditioned plasma (ACP) ClinicalTrials.gov intervention name — accepted as the source's own label NCT01414764 ↗
Route Other “ACP (1ml) (extracted from centrifuged venous sample), with additional calcium chloride is then injected into the tendon-bone junction and adjacent area under guided ultrasound.” NCT01414764 ↗